Physician profile
Dee Dee Wang
NPI 1225151061
$173,190.04
in general payments reported to CMS, 2019-2025
17 companies · $1,026 in 2025
The $1,026 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $1,017 · 2021: $16K · 2022: $13K · 2023: $20K · 2024: $92K · 2025: $1,026.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $54K · Travel and Lodging: $35K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Food and Beverage: $3,858 · Grant: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $54,375.00 |
| Travel and Lodging | $34,804.59 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,150.00 |
| Food and Beverage | $3,857.51 |
| Grant | $134.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $129,805.48 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque, Pascal |
| Abbott Laboratories | $24,516.44 | 2019-2025 | Mitraclip, Triclip, Portico |
| Boston Scientific Corporation | $10,854.41 | 2019-2024 | |
| Materialise Nv | $4,000.00 | 2019 | |
| Siemens Medical Solutions USA, INC. | $2,711.13 | 2023 | |
| Inari Medical, INC. | $500.00 | 2022 | |
| Medtronic Vascular, INC. | $273.64 | 2019-2020 | |
| Jenavalve Technology, INC. | $160.28 | 2023 | Jenavalve Pericardial Tavr System |
| Medtronic, INC. | $113.10 | 2023-2025 | Aurora Ev-Icd Mri Surescan, Corevalve Evolut R |
| Cardiva Medical, INC. | $64.57 | 2024-2025 | Savvywire |
| Heartflow, INC. | $53.12 | 2025 | |
| Cleerly, INC. | $34.24 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Kestra Medical Technology Services, INC. | $26.59 | 2025 | Assure Wcd |
| Scpharmaceuticals INC. | $24.98 | 2024 | |
| Chiesi USA, INC. | $22.35 | 2023 | Kengreal, Cleviprex |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.52 | 2025 | |
| Amgen INC. | $13.19 | 2023 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dee Dee Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.